Buckingham Capital Management Upped Its Carnival (CCL) Position; Intersect ENT (XENT) Covered By 6 Bullish Analysts Last Week

November 15, 2017 - By Peter Erickson

Buckingham Capital Management Inc increased Carnival Corp (CCL) stake by 2.9% reported in 2017Q2 SEC filing. Buckingham Capital Management Inc acquired 5,711 shares as Carnival Corp (CCL)’s stock rose 11.01%. The Buckingham Capital Management Inc holds 202,561 shares with $13.28M value, up from 196,850 last quarter. Carnival Corp now has $47.35B valuation. The stock declined 0.55% or $0.36 reaching $65.66 on the news. About 174 shares traded. Carnival Corp (NYSE:CCL) has risen 24.12% since November 15, 2016 and is uptrending. It has outperformed by 7.42% the S&P500.

Among 9 analysts covering Intersect ENT (NASDAQ:XENT), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Intersect ENT had 17 analyst reports since August 17, 2015 according to SRatingsIntel. The company was downgraded on Wednesday, November 2 by JP Morgan. The firm has “Market Perform” rating given on Wednesday, May 31 by Northland Capital. The firm has “Hold” rating given on Thursday, October 6 by Deutsche Bank. Piper Jaffray maintained the stock with “Overweight” rating in Tuesday, September 29 report. The firm has “Hold” rating by Northland Capital given on Wednesday, August 2. The firm earned “Buy” rating on Monday, August 21 by Piper Jaffray. The stock has “Buy” rating by Bank of America on Friday, December 18. The company was maintained on Thursday, October 1 by Canaccord Genuity. Northland Capital initiated it with “Outperform” rating and $26 target in Tuesday, March 29 report. Canaccord Genuity maintained the shares of XENT in report on Monday, October 16 with “Buy” rating. See Intersect ENT Inc (NASDAQ:XENT) latest ratings:

06/11/2017 Broker: BTIG Research Rating: Hold
16/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $37.0 Maintain
13/09/2017 Broker: Canaccord Genuity Rating: Buy Old Target: $32 New Target: $37 Maintain
21/08/2017 Broker: Piper Jaffray Rating: Buy New Target: $35.0 Maintain
01/08/2017 Broker: Canaccord Genuity Rating: Buy New Target: $32.0000
02/08/2017 Broker: Northland Capital Rating: Hold New Target: $25.0000 Maintain
02/08/2017 Broker: Deutsche Bank Rating: Buy Old Target: $27 New Target: $31 Maintain
31/05/2017 Broker: Northland Capital Old Rating: Outperform New Rating: Market Perform Downgrade

Intersect ENT, Inc. is a commercial-stage drug-device company. The company has market cap of $830.66 million. The Firm develops drugs for patients with ear, nose and throat conditions. It currently has negative earnings. The Firm has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents.

It closed at $28.2 lastly. It is down 79.98% since November 15, 2016 and is uptrending. It has outperformed by 63.28% the S&P500.

Buckingham Capital Management Inc decreased Ensco Plc Com Stk (NYSE:ESV) stake by 242,038 shares to 840,849 valued at $4.34M in 2017Q2. It also reduced Toll Brothers Inc Com Stk (NYSE:TOL) stake by 34,347 shares and now owns 320,053 shares. Phillips Van Heusen Corp Com S (NYSE:PVH) was reduced too.

Among 27 analysts covering Carnival Corporation (NYSE:CCL), 17 have Buy rating, 1 Sell and 9 Hold. Therefore 63% are positive. Carnival Corporation had 58 analyst reports since August 6, 2015 according to SRatingsIntel. Credit Suisse maintained the shares of CCL in report on Wednesday, September 23 with “Outperform” rating. Wedbush maintained Carnival Corp (NYSE:CCL) on Wednesday, March 29 with “Neutral” rating. The firm has “Outperform” rating given on Wednesday, November 23 by Bernstein. The company was upgraded on Tuesday, March 21 by William Blair. The firm has “Buy” rating by SunTrust given on Thursday, March 31. The stock of Carnival Corp (NYSE:CCL) earned “Buy” rating by Tigress Financial on Monday, October 2. On Monday, December 19 the stock rating was downgraded by Berenberg to “Hold”. The firm has “Neutral” rating given on Tuesday, October 4 by Macquarie Research. The firm has “Outperform” rating given on Friday, May 26 by Wolfe Research. The firm has “Buy” rating by Buckingham Research given on Wednesday, November 4.

Investors sentiment decreased to 1.12 in Q2 2017. Its down 0.03, from 1.15 in 2017Q1. It turned negative, as 38 investors sold CCL shares while 225 reduced holdings. 89 funds opened positions while 205 raised stakes. 408.62 million shares or 0.87% less from 412.20 million shares in 2017Q1 were reported. Covenant Multifamily Offices Limited Liability Corporation holds 1.66% or 39,931 shares. Northern Trust Corporation holds 25.89 million shares or 0.47% of its portfolio. Rampart Mgmt Com has 5,443 shares for 0.13% of their portfolio. Black Creek Investment Management holds 3.88% of its portfolio in Carnival Corp (NYSE:CCL) for 1.12 million shares. Ballentine Prtn Limited Liability has invested 0.02% in Carnival Corp (NYSE:CCL). Delta Asset Mgmt Limited Liability Co Tn invested 0% in Carnival Corp (NYSE:CCL). Barrow Hanley Mewhinney Strauss Limited Liability invested in 7.56M shares or 0.75% of the stock. State Of Alaska Department Of Revenue reported 0.03% stake. Perella Weinberg Prtnrs Mgmt Lp holds 0.13% or 15,692 shares in its portfolio. Pension owns 368,862 shares. Huntington State Bank holds 17,259 shares. D E Shaw & holds 712,468 shares or 0.08% of its portfolio. Paragon Mngmt Ltd holds 0.32% in Carnival Corp (NYSE:CCL) or 10,526 shares. Gradient Ltd Limited Liability Company, a Minnesota-based fund reported 106,534 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.12% or 184,873 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com